Locally Advanced Non Small Cell Lung Cancer: The Case for Radiation Dose De-escalation in the Management of the Mediastinum.
作者信息
Soyfer Viacheslav, Corn Benjamin W
机构信息
Tel Aviv Medical Center, Tel Aviv University, Tel Aviv, Israel.
Shaare Zedek Medical Center, Hebrew University of Jerusalem, Jerusalem, Israel.
出版信息
Front Oncol. 2019 Apr 16;9:283. doi: 10.3389/fonc.2019.00283. eCollection 2019.
Abstract
摘要
相似文献
1
Locally Advanced Non Small Cell Lung Cancer: The Case for Radiation Dose De-escalation in the Management of the Mediastinum.局部晚期非小细胞肺癌：纵隔治疗中降低放射剂量的理由
Front Oncol. 2019 Apr 16;9:283. doi: 10.3389/fonc.2019.00283. eCollection 2019.
2
Intensity-modulated radiotherapy for locally advanced non-small-cell lung cancer: a dose-escalation planning study.调强放疗局部晚期非小细胞肺癌：剂量递增计划研究。
Int J Radiat Oncol Biol Phys. 2011 May 1;80(1):306-13. doi: 10.1016/j.ijrobp.2010.06.025. Epub 2010 Oct 1.
3
The use of dose-escalated radiation for locally advanced non-small cell lung cancer in the U.S., 2004-2013.2004年至2013年美国局部晚期非小细胞肺癌剂量递增放疗的应用情况
Radiat Oncol. 2017 Jan 17;12(1):19. doi: 10.1186/s13014-016-0755-y.
4
Dose escalation for non-small cell lung cancer using conformal radiation therapy.使用适形放射疗法对非小细胞肺癌进行剂量递增。
Int J Radiat Oncol Biol Phys. 1997 Mar 15;37(5):1079-85. doi: 10.1016/s0360-3016(96)00593-7.
5
Radiation dose escalation by percutaneous interstitial brachytherapy in locally advanced non-small cell lung cancer.
Indian J Chest Dis Allied Sci. 2009 Apr-Jun;51(2):103-6.
6
Strategy for dose escalation using 3-dimensional conformal radiation therapy for lung cancer.使用三维适形放射治疗的肺癌剂量递增策略。
Ann Oncol. 1995 Sep;6(7):693-7. doi: 10.1093/oxfordjournals.annonc.a059286.
7
Potential for reduced toxicity and dose escalation in the treatment of inoperable non-small-cell lung cancer: a comparison of intensity-modulated radiation therapy (IMRT), 3D conformal radiation, and elective nodal irradiation.不可切除的非小细胞肺癌治疗中降低毒性和增加剂量的潜力：调强放射治疗（IMRT）、三维适形放疗和选择性淋巴结照射的比较
Int J Radiat Oncol Biol Phys. 2003 Nov 1;57(3):875-90. doi: 10.1016/s0360-3016(03)00743-0.
8
Three-dimensional conformal radiation therapy for non-small-cell lung cancer: a phase I/II dose escalation clinical trial.非小细胞肺癌的三维适形放射治疗：一项I/II期剂量递增临床试验。
Int J Radiat Oncol Biol Phys. 2003 Dec 1;57(5):1336-44. doi: 10.1016/s0360-3016(03)01385-3.
9
Results of a trial with topotecan dose escalation and concurrent thoracic radiation therapy for locally advanced, inoperable nonsmall cell lung cancer.拓扑替康剂量递增联合同期胸部放疗治疗局部晚期不可切除非小细胞肺癌的试验结果
Int J Radiat Oncol Biol Phys. 1996 Dec 1;36(5):1215-20. doi: 10.1016/s0360-3016(96)00367-7.
10
The impact of three-dimensional radiation on the treatment of non-small cell lung cancer.
Radiother Oncol. 2000 Aug;56(2):157-67. doi: 10.1016/s0167-8140(00)00207-3.
引用本文的文献
1
Is immunotherapy at reduced dose and radiotherapy for older patients with locally advanced non-small lung cancer feasible?-a narrative review by the international geriatric radiotherapy group.低剂量免疫疗法联合放疗用于老年局部晚期非小细胞肺癌患者是否可行？——国际老年放疗组的叙述性综述
Transl Cancer Res. 2022 Sep;11(9):3298-3308. doi: 10.21037/tcr-22-821.
本文引用的文献
1
Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC.度伐利尤单抗化疗和放疗后用于 III 期非小细胞肺癌的总生存。
N Engl J Med. 2018 Dec 13;379(24):2342-2350. doi: 10.1056/NEJMoa1809697. Epub 2018 Sep 25.
2
Concurrent Daily Cisplatin and High-Dose Radiation Therapy in Patients With Stage III Non-Small Cell Lung Cancer.同期每日顺铂与高剂量放疗治疗 III 期非小细胞肺癌患者。
Int J Radiat Oncol Biol Phys. 2018 Nov 1;102(3):543-551. doi: 10.1016/j.ijrobp.2018.07.188. Epub 2018 Jul 25.
3
Durvalumab after Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer.Durvalumab 用于 III 期非小细胞肺癌放化疗后的治疗。
N Engl J Med. 2017 Nov 16;377(20):1919-1929. doi: 10.1056/NEJMoa1709937. Epub 2017 Sep 8.
4
Randomized Phase II Study of Preoperative Chemoradiotherapy ± Panitumumab Followed by Consolidation Chemotherapy in Potentially Operable Locally Advanced (Stage IIIa, N2+) Non-Small Cell Lung Cancer: NRG Oncology RTOG 0839.术前放化疗±帕尼单抗序贯巩固化疗用于潜在可切除的局部晚期（Ⅲa期，N2+）非小细胞肺癌的随机II期研究：NRG肿瘤学RTOG 0839
J Thorac Oncol. 2017 Sep;12(9):1413-1420. doi: 10.1016/j.jtho.2017.06.007. Epub 2017 Jun 16.
5
Is there a different dose-effect relation between the primary tumor and involved lymph nodes in locally advanced non-small-cell lung cancer? A hypothesis-generating study.局部晚期非小细胞肺癌中原发肿瘤与受累淋巴结之间是否存在不同的剂量效应关系？一项产生假设的研究。
Acta Oncol. 2017 Apr;56(4):541-547. doi: 10.1080/0284186X.2017.1293288. Epub 2017 Feb 26.
6
Cardiac Toxicity After Radiotherapy for Stage III Non-Small-Cell Lung Cancer: Pooled Analysis of Dose-Escalation Trials Delivering 70 to 90 Gy.Ⅲ期非小细胞肺癌放疗后的心脏毒性：70至90 Gy剂量递增试验的汇总分析
J Clin Oncol. 2017 May 1;35(13):1387-1394. doi: 10.1200/JCO.2016.70.0229. Epub 2017 Jan 23.
7
Impact of Intensity-Modulated Radiation Therapy Technique for Locally Advanced Non-Small-Cell Lung Cancer: A Secondary Analysis of the NRG Oncology RTOG 0617 Randomized Clinical Trial.调强放射治疗技术对局部晚期非小细胞肺癌的影响：NRG肿瘤学RTOG 0617随机临床试验的二次分析
J Clin Oncol. 2017 Jan;35(1):56-62. doi: 10.1200/JCO.2016.69.1378. Epub 2016 Oct 31.
8
A genome-based model for adjusting radiotherapy dose (GARD): a retrospective, cohort-based study.一种基于基因组的放疗剂量调整模型（GARD）：一项基于队列的回顾性研究。
Lancet Oncol. 2017 Feb;18(2):202-211. doi: 10.1016/S1470-2045(16)30648-9. Epub 2016 Dec 18.
9
Response-adapted volume de-escalation (RAVD) in locally advanced head and neck cancer.局部晚期头颈部肿瘤的自适应剂量调整（RAVD）。
Ann Oncol. 2016 May;27(5):908-13. doi: 10.1093/annonc/mdw051. Epub 2016 Feb 15.
10
Differences Between Colon Cancer Primaries and Metastases Using a Molecular Assay for Tumor Radiation Sensitivity Suggest Implications for Potential Oligometastatic SBRT Patient Selection.使用肿瘤放射敏感性分子检测方法对结肠癌原发灶和转移灶的差异表明对潜在寡转移SBRT患者选择的启示。
Int J Radiat Oncol Biol Phys. 2015 Jul 15;92(4):837-42. doi: 10.1016/j.ijrobp.2015.01.036. Epub 2015 Mar 30.
Zotero 插件